Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Isradipine.

¹Department of Clinical Pharmacology, St Mary's Hospital, London, U.K.

Journal of Clinical Pharmacy and Therapeutics

|April 1, 1991

Summary

This summary is machine-generated.

Isradipine, a calcium channel blocker, effectively treats hypertension with minimal cardiac side effects. Further research is exploring its benefits in other cardiovascular conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Morphology assessment and fluorescence in situ hybridization of the same spermatozoon using a computerized cell-scanning system.

Human reproduction (Oxford, England)·2006

Same author

Meiotic arrest in vitro by phosphodiesterase 3-inhibitor enhances maturation capacity of human oocytes and allows subsequent embryonic development.

Biology of reproduction·2005

Same author

The use of ezetimibe in achieving low density lipoprotein lowering goals in clinical practice: position statement of a United Kingdom consensus panel.

Current medical research and opinion·2005

Same author

The outcome of ICSI of immature MI oocytes and rescued in vitro matured MII oocytes.

Human reproduction (Oxford, England)·2004

Same author

Antihypertensive efficacy of moxonidine in primary care: a 'real-life' study.

International journal of clinical practice·2003

Same author

Coasting-what is the best formula?

Human reproduction (Oxford, England)·2003

Same journal

Impact of pharmacist-initiated educational interventions on improving medication reconciliation practice in geriatric inpatients during hospital admission in Vietnam.

Journal of clinical pharmacy and therapeutics·2022

Same journal

Evaluation of off-label anti-vascular endothelial growth factor and steroid implant medication uses in macular edema due to retinal vein occlusion in Turkey.

Journal of clinical pharmacy and therapeutics·2022

Same journal

A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population.

Journal of clinical pharmacy and therapeutics·2022

Same journal

Effects of caregiver counselling on medication persistence and adherence in patients with dementia at a pharmacist-managed clinic: A pilot study.

Journal of clinical pharmacy and therapeutics·2022

Same journal

The 50% and 95% effective doses of remimazolam tosilate with adjuvant sufentanil for sedation in patients with liver cirrhosis undergoing oesophagogastric varices screening endoscopy.

Journal of clinical pharmacy and therapeutics·2022

Same journal

Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two-centre, retrospective, cohort study.

Journal of clinical pharmacy and therapeutics·2022

See all related articles

Area of Science:

Cardiology
Pharmacology

Background:

Isradipine is a dihydropyridine calcium channel blocker.
It exhibits high selectivity for vascular smooth muscle.
It has minimal negative inotropic or chronotropic effects.

Purpose of the Study:

To evaluate the efficacy and safety of Isradipine in managing essential hypertension.
To explore potential benefits in stable angina and congestive cardiac failure.
To assess its antiatherogenic properties.

Main Methods:

Clinical trials and evidence-based reviews were used.
Efficacy in monotherapy and combination therapy was assessed.
Adverse effects were compared to similar vasodilators.

Main Results:

Related Experiment Videos

Isradipine is effective as monotherapy for essential hypertension.
It shows potential benefits in stable angina and congestive cardiac failure.
Adverse effects may be less frequent than with nifedipine.

Conclusions:

Isradipine is a favorable option for hypertensive patients requiring a calcium channel blocker, especially when avoiding myocardial depression or reflex tachycardia is desired.
Its role in other cardiovascular diseases requires further investigation.